On Monday alone, fund managers were inundated with pre-deal marketing reports from KKR’s pubs group Australian Venue Co and Luye Group’s Aurora Health Care, as well as the launch of Australian Clinical Labs’ $408.6 million bookbuild.
That’s not to mention this column smoking out the next $1 billion-plus float candidate, Keypath Education, and non-bank lender Pepper Money also doing the rounds.
It’s fair to say the float pipeline is fit to bursting - and it’s not being clogged up by tiddlers. By our back-of-the-envelope calculations, the combined market cap of the five floats above should eclipse the $6 billion mark.
In tonight’s column, we take a closer look at Keypath and Australian Clinical Labs.
Insurance seller and one-time initial public offering candidate Greenstone has launched a strategic review that will consider exit options for the group’s private equity investor, Canadian giant CDPQ.
You have received this email because you are subscribed to Street Talk First Look with the email address: newsletter@newslettercollector.com
